Business Description
Grifols SA
ISIN : ES0171996095
Share Class Description:
MEX:GRFP N: PRF PERPETUAL EUR 0.05 - Cls BTotal Employee Number:
25,247Description
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | 0.28 | |||||
Debt-to-Equity | 1.54 | |||||
Debt-to-EBITDA | 5.35 | |||||
Interest Coverage | 2.5 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.06 | |||||
Beneish M-Score | -2.61 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.4 | |||||
3-Year EBITDA Growth Rate | 11.1 | |||||
3-Year EPS without NRI Growth Rate | 35.3 | |||||
3-Year Book Growth Rate | -2.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.37 | |||||
Quick Ratio | 0.81 | |||||
Cash Ratio | 0.24 | |||||
Days Inventory | 264.51 | |||||
Days Sales Outstanding | 38.85 | |||||
Days Payable | 70.8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Payout Ratio | 0.37 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 4.35 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 37 | |||||
Operating Margin % | 16.24 | |||||
Net Margin % | 6.11 | |||||
EBITDA Margin % | 21.47 | |||||
FCF Margin % | 8.78 | |||||
OCF Margin % | 14.84 | |||||
ROE % | 8.51 | |||||
ROA % | 2.28 | |||||
ROIC % | 5.29 | |||||
3-Year ROIIC % | -23.71 | |||||
ROC (Joel Greenblatt) % | 18.48 | |||||
ROCE % | 6.47 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 7 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 15.28 | |||||
Forward PE Ratio | 7.17 | |||||
PE Ratio without NRI | 15.28 | |||||
Shiller PE Ratio | 11.97 | |||||
Price-to-Owner-Earnings | 13.21 | |||||
PEG Ratio | 2.5 | |||||
PS Ratio | 0.93 | |||||
PB Ratio | 1.25 | |||||
Price-to-Free-Cash-Flow | 10.76 | |||||
Price-to-Operating-Cash-Flow | 6.33 | |||||
EV-to-EBIT | 14.35 | |||||
EV-to-Forward-EBIT | 14.54 | |||||
EV-to-EBITDA | 10.37 | |||||
EV-to-Forward-EBITDA | 10.28 | |||||
EV-to-Revenue | 2.23 | |||||
EV-to-Forward-Revenue | 2.23 | |||||
EV-to-FCF | 25.67 | |||||
Price-to-GF-Value | 0.96 | |||||
Price-to-Projected-FCF | 0.9 | |||||
Price-to-DCF (Earnings Based) | 0.73 | |||||
Price-to-DCF (FCF Based) | 0.51 | |||||
Price-to-Median-PS-Value | 0.31 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.4 | |||||
Earnings Yield (Greenblatt) % | 6.97 | |||||
FCF Yield % | 10.56 | |||||
Forward Rate of Return (Yacktman) % | 15.58 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Grifols SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 154,835.829 | ||
| EPS (TTM) (MXN) | 13.866 | ||
| Beta | -0.3072 | ||
| 3-Year Sharpe Ratio | -0.21 | ||
| 3-Year Sortino Ratio | -0.32 | ||
| Volatility % | 2.84 | ||
| 14-Day RSI | - | ||
| 14-Day ATR (MXN) | - | ||
| 20-Day SMA (MXN) | 126.63 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (MXN) | 126.63 - 126.63 | ||
| Shares Outstanding (Mil) | 680.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Grifols SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Grifols SA Stock Events
| Event | Date | Price (MXN) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-04 18:30 | In 88 days | ||
| Third quarter earnings results for 2026 | 2026-11-04 | In 86 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-28 18:30 | 126.63 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-07-28 17:35 | 126.63 (+0.00%) | ||
| EUR 0.092503 Cash Dividend | 2026-07-01 | 126.63 (+0.00%) | ||
| General meeting for 2026 | 2026-06-17 12:00 | 126.63 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-07 12:30 | 126.63 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-07 | 126.63 (+0.00%) | ||
| Annual report for 2025 | 2026-02-27 | 126.63 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-26 12:30 | 126.63 (+0.00%) |
Show
Entries
Grifols SA Frequently Asked Questions
What is Grifols SA(MEX:GRFP N)'s stock price today?
The current price of MEX:GRFP N is MXN126.63. The 52 week high of MEX:GRFP N is MXN126.63 and 52 week low is MXN126.63.
When is next earnings date of Grifols SA(MEX:GRFP N)?
The next earnings date of Grifols SA(MEX:GRFP N) is 2026-11-04 Est..
Does Grifols SA(MEX:GRFP N) pay dividends? If so, how much?
Grifols SA(MEX:GRFP N) does not pay dividend.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers